EVENTS|NEWS|CONTACT|DONATE

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Read Our Newsletter

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

helico bacter pylori stomach inflammation

How inflammation causes gastric cancer

In a study, scientists blocked a protein pathway that causes the proliferation of gastric epithelial cells from H. Pylori infection and prevented stomach tumors from forming in mice.

helicobacter pylori, inflammation, prevention

Share Post:

Intestinal and diffuse gastric cancer: a retrospective study comparing primary sites

Merck Provides Update on Phase 3 KEYNOTE-062 Trial Evaluating KEYTRUDA

Social Media

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Categories

Foundation News
Press Releases
Research News

Tags

adenocarcenoma advanced stage alcohol antibody biomarker blood chemoradiotherapy chemotherapy clinical trial clinical trials detection drugs endoscopy Epstein-Barr esophagogastric FDA gastrectomy gastric cancer registry gastroesophageal genes heartburn helicobacter pylori HER2 immunotherapy keytruda lonsurf metastatic nutrition peritoneal postoperative prevention proton pump inhibitor recovery recurrence research risk screening side-effects studies surgery survival treatment tumor virus women

Gastric Cancer Foundation

Tax ID 27-2978173

info@gastriccancer.org

PO Box 338
Millbrae, CA 94030

For Deliveries:
Gastric Cancer Foundation
501 Broadway, #338
Millbrae, CA 94030-1907

Site Map

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Social Feed

Gastric Cancer Foundation

2 hours ago

The new gastric cancer treatment Vyloy (zolbetuximab-clzb), which targets the tumor protein claudin 18.2, “is an important step forward for patients suffering from this serious and often fatal cancer,” said Professor Florian Lordick, Director of the University Cancer Center Leipzig, which was a clinical trial site for the drug. ... See MoreSee Less

Drug Extends Survival in Gastric Cancer Clinical Trial

www.technologynetworks.com

A new study reveals that gastric cancer patients treated with zolbetuximab live longer.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

4 days ago

Stomach cancer is the fourth leading cause of cancer deaths worldwide, yet it receives less than one-half of one percent (0.4%) of US federal cancer research funding. Your generosity will fuel research and provide people with stomach cancer the information, support, and hope they need to navigate their journey. ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

5 days ago

The U.S. Food and Drug Administration approved a first-in-class medicine, Vyloy (zolbetuximab-clzb), an antibody that targets the protein claudin 18.2. In trials in patients with gastric cancer whose tumors test positive for claudin 18.2, the drug extended progression-free survival when combined with chemotherapy. ... See MoreSee Less

FDA approves zolbetuximab-clzb with chemotherapy

www.fda.gov

On October 18, 2024, the FDA approved zolbetuximab-clzb (Vyloy, Astellas Pharma US, Inc.) with fluoropyrimidine- and platinum-containing chemotherapy for gastric or gastroesophageal junction adenocarc...

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

6 days ago

An analysis published in Cancer by American Cancer Society revealed that aspirin use had a protective effect that was strongest in people without a family history of gastric cancer. Statin use did not protect against the disease. ... See MoreSee Less

Aspirin Linked to Lower Risk of Gastric Cancer

www.cancertherapyadvisor.com

Aspirin use is associated with a decreased risk of gastric cancer, but statin use is not, a study suggests.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

"I Was Diagnosed With Stomach Cancer at 32. Here Are the First Symptoms I Noticed,” via SELF Magazine. ... See MoreSee Less

I Was Diagnosed With Stomach Cancer at 32. Here Are the First Symptoms I Noticed

www.self.com

I kept calling my doctor’s office for updates, but the receptionist told me he was busy.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Subscribe to Our Newsletter

We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.

© 2024 Gastric Cancer Foundation. All Rights Reserved.

EVENTS | NEWS | CONTACT | DONATE

Please join with us to fuel the next wave of progress.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Please join with us to fuel the next wave of progress. Support our 2024 Fundraising Campaign.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Together, we will defeat stomach cancer.

Together, we will defeat stomach cancer.

MORE INFO DONATE

X